ENDVライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 23:45):

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine...

Stats
本日の出来高	12 836.00
平均出来高	1.21M
時価総額	838 318
EPS	$-0.0100 ( 2023-08-21 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0.260
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2020-07-01	Collier Alan Brian	Buy	100	Common Stock
2020-07-01	Collier Alan Brian	Buy	100	Common Stock
2020-06-30	Collier Alan Brian	Buy	200	Common Stock
2020-02-22	Collier Alan Brian	Buy	100	Common Stock
2020-01-02	Collier Alan Brian	Buy	100	Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 301 200 \| Sell: 0

Endonovo Therapeutics, 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Endonovo Therapeutics, 財務諸表

Annual	2023
収益:	$140 242
総利益:	$-514 510 (-366.87 %)
EPS:	$0.0251

FY	2023
収益:	$140 242
総利益:	$-514 510 (-366.87 %)
EPS:	$0.0251

FY	2022
収益:	$135 355
総利益:	$125 365 (92.62 %)
EPS:	$-0.230

FY	2021
収益:	$73 105.00
総利益:	$58 120.00 (79.50 %)
EPS:	$-0.0500

Financial Reports:

No articles found.

Endonovo Therapeutics,

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.